The Howard T. Ricketts Laboratory
The HTRL is a Regional Biocontainment Laboratory, one of 13 located throughout the United States constructed by partnerships between the National Institute of Allergy and Infectious Diseases and local academic institutions
- Plague: Ricketts lab researchers are at the forefront of Plague vaccine development... Read more »
- Anthrax: Here at the Ricketts lab, we are developing an anti- infective therapy for anthrax... Read more »
- MRSA: Studies are also planned to evaluate the ability of the high-affinity T cell receptor chains to neutralize superantigens... Read more »
- Conferences: 2013 RCE National Meeting, April 7–9, 2013, Seattle, Washington Learn More »
- Publications: Quenee LE, Hermanas TM, Ciletti N, Louvel H, Miller NC, Eli D, Blaylock B, Mitchell A, Schroeder J, Krausz T, Kanabrocki J, Schneewind O. (2012) Hereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains.J Infect Dis. (2012) 206 (7): 1050-1058. Pubmed Abstract »
